Feature Story
In a first, U.S. trial to test Cuban lung-cancer vaccine
THURSDAY, October 27, 2016 (The Washington Post)– The Food and Drug Administration has approved the first clinical trial to test a Cuban drug in the United States — a lung-cancer vaccine developed in Havana.
The decision on the early-stage trial was announced Wednesday by New York Gov. Andrew Cuomo (D) and officials at the Roswell Park Cancer Institute, based in Buffalo. The trial could start as soon as next month and will enroll 60 to 90 patients. It is likely to take three years to complete.
You might have also missed…
30% of Cancer Deaths Are Due to Smoking
Oct 24, TIME
The startling rise in oral cancer in men, and what it says about our changing sexual habits
Oct 25, The Washington Post
A Noninvasive Colon Cancer Test That’s FIT To Be Tried
Oct 24, NPR
Olympic Swimmer Takes to Instagram to Thank Fan for Sounding Alarm on Chest Mole
Oct 25, ABC News
